Literature DB >> 19284297

The selection and application of ssDNA aptamers against MPT64 protein in Mycobacterium tuberculosis.

Lianhua Qin1, Ruijuan Zheng, Zhanzhong Ma, Yonghong Feng, Zhonghua Liu, Hua Yang, Jie Wang, Ruiliang Jin, Junmei Lu, Yuansheng Ding, Zhongyi Hu.   

Abstract

BACKGROUND: Tuberculosis (TB) remains a major health problem affecting millions of people worldwide. One-third of the world's population is infected with Mycobacterium tuberculosis, the etiologic agent of TB. A simple and rapid method to diagnose TB is urgently needed to be developed. The procedure of systematic evolution of ligands by exponential enrichment (SELEX) is a method in which single-stranded oligonucleotides (called aptamers) are selected from a wide variety of sequences, based on their interaction with a target molecule. Aptamers have been used in numerous investigations as therapeutic or diagnostic tools.
METHODS: In this study, we apply a SELEX method to develop aptamers against MPT64 protein from M. tuberculosis. On this basis, a sandwich assay scheme with the complex of aptamer-MPT64 was designed and tested the feasibility of detecting M. tuberculosis by detecting MPT64 protein levels in the culture filtrates of 77 samples including M. tuberculosis and other Mycobacterium species.
RESULTS: There was a highly significant difference (p<0.01) between group A (non-TB Mycobacterium, bacille Calmette-Guérin) and group B (M. tuberculosis, M. bovis), when they were diagnosed with the sandwich assay scheme based on aptamer-protein complex to detect MPT64 protein levels in the culture filtrates of samples. When the cut-off point was at the optical density value of 0.58 (95%=0.764-0.946; Z=6.130, p=0.0001), the sandwich assay scheme based on aptamer-protein complex had a high sensitivity (negative ration, 24/27, 86.3%) and specificity (positive ration, 46/52, 88.5%).
CONCLUSIONS: Aptamer of MPT64 as a new detection tool, to a certain extent, is feasible to diagnose Mycobacterium tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19284297     DOI: 10.1515/CCLM.2009.097

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  12 in total

1.  Dynamic evolution and immunoreactivity of aptamers binding to polyclonal antibodies against MPT64 antigen of Mycobacterium tuberculosis.

Authors:  L-H Qin; Z-H Liu; H Yang; J-L Cai; W-J Bai; J Wang; J-M Liu; Z-Y Hu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-07       Impact factor: 3.267

2.  Dual-aptamer-based voltammetric biosensor for the Mycobacterium tuberculosis antigen MPT64 by using a gold electrode modified with a peroxidase loaded composite consisting of gold nanoparticles and a Zr(IV)/terephthalate metal-organic framework.

Authors:  Ningning Li; Xing Huang; Duanping Sun; Weiye Yu; Weiguo Tan; Zhaofan Luo; Zuanguang Chen
Journal:  Mikrochim Acta       Date:  2018-11-12       Impact factor: 5.833

3.  Aptamer against mannose-capped lipoarabinomannan inhibits virulent Mycobacterium tuberculosis infection in mice and rhesus monkeys.

Authors:  Qin Pan; Qilong Wang; Xiaoming Sun; Xianru Xia; Shimin Wu; Fengling Luo; Xiao-Lian Zhang
Journal:  Mol Ther       Date:  2014-02-27       Impact factor: 11.454

4.  Selection and application of ssDNA aptamers to detect active TB from sputum samples.

Authors:  Lia S Rotherham; Charlotte Maserumule; Keertan Dheda; Jacques Theron; Makobetsa Khati
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

Review 5.  Single-Stranded DNA Aptamers against Pathogens and Toxins: Identification and Biosensing Applications.

Authors:  Ka Lok Hong; Letha J Sooter
Journal:  Biomed Res Int       Date:  2015-06-23       Impact factor: 3.411

Review 6.  Aptamers in the Therapeutics and Diagnostics Pipelines.

Authors:  Harleen Kaur; John G Bruno; Amit Kumar; Tarun Kumar Sharma
Journal:  Theranostics       Date:  2018-07-01       Impact factor: 11.556

7.  Sensing of mycobacterial arabinogalactan by galectin-9 exacerbates mycobacterial infection.

Authors:  Xiangyang Wu; Yong Wu; Ruijuan Zheng; Fen Tang; Lianhua Qin; Detian Lai; Lu Zhang; Lingming Chen; Bo Yan; Hua Yang; Yang Wang; Feifei Li; Jinyu Zhang; Fei Wang; Lin Wang; Yajuan Cao; Mingtong Ma; Zhonghua Liu; Jianxia Chen; Xiaochen Huang; Jie Wang; Ruiliang Jin; Peng Wang; Qin Sun; Wei Sha; Liangdong Lyu; Pedro Moura-Alves; Anca Dorhoi; Gang Pei; Peng Zhang; Jiayu Chen; Shaorong Gao; Felix Randow; Gucheng Zeng; Chang Chen; Xin-Shan Ye; Stefan H E Kaufmann; Haipeng Liu; Baoxue Ge
Journal:  EMBO Rep       Date:  2021-05-13       Impact factor: 8.807

Review 8.  Aptamers against pathogenic microorganisms.

Authors:  Anna Davydova; Maria Vorobjeva; Dmitrii Pyshnyi; Sidney Altman; Valentin Vlassov; Alya Venyaminova
Journal:  Crit Rev Microbiol       Date:  2015-08-10       Impact factor: 7.624

Review 9.  Selection and analytical applications of aptamers binding microbial pathogens.

Authors:  Camille L A Hamula; Hongquan Zhang; Feng Li; Zhixin Wang; X Chris Le; Xing-Fang Li
Journal:  Trends Analyt Chem       Date:  2011-09-09       Impact factor: 12.296

Review 10.  Oligonucleotide aptamers: promising and powerful diagnostic and therapeutic tools for infectious diseases.

Authors:  Qin Pan; Fengling Luo; Min Liu; Xiao-Lian Zhang
Journal:  J Infect       Date:  2018-05-07       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.